PathogenDx, a leader in next-generation microarray technology for better health and safety, saw a two-year 276% uptick in revenue and was the recipient of numerous awards and honors, including the Deloitte Technology Fast 500, Fast Company World Changing Ideas Award and Inc. Magazine 5000.